Blood lead level risk factors and reference value derivation in a cross-sectional study of potentially lead-exposed workers in Iran.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
02 07 2019
Historique:
entrez: 5 7 2019
pubmed: 5 7 2019
medline: 24 7 2020
Statut: epublish

Résumé

This exploratory investigation aimed to measure blood lead levels and associated risk factors in exposed workers in Iran, and to derive appropriate reference values for blood lead in this population as a means of epidemiological comparison. Cross-sectional. Manufacturing plants with potential lead exposure in Southern Khorasan Province, Iran. The study included 630 workers, selected through stratified random sampling. The primary measures in this exploratory investigation were venous blood lead concentration (BLC) and associated risk factors of age, gender, work experience, cigarette smoking and history of opium use. The secondary measures were symptoms associated with lead toxicity. Data analyses were conducted using Student's t-test, Mann-Whitney U test, one-way analysis of variance, Kruskal-Wallis test, Spearman correlation coefficient and regression analysis. Mean and median BLCs were 6.5±8.1 μg/dL and 3.9 μg/dL (IQR: 2.9-5.8), respectively. Of the subjects, 85 (13.5%) had BLC ≥10 μg/dL. The derived reference BLC value in this study was 30 μg/dL for men and 14 μg/dL for women. Increasing work experience and age were associated with BLC >10 μg/dL. Radiator manufacturers were up to 12.9 times (95% CI 4.6 to 35, p<0.005) more likely than painters to have BLC >10 μg/dL. Most subjects reported multiple symptoms. The mean BLC was above the maximum recommended concentration. There was a significant relationship between higher BLC and age or working in a printing factory or radiator manufacturing. These findings can direct efforts towards reducing occupational lead exposure.

Identifiants

pubmed: 31270112
pii: bmjopen-2018-023867
doi: 10.1136/bmjopen-2018-023867
pmc: PMC6609121
doi:

Substances chimiques

Lead 2P299V784P

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e023867

Informations de copyright

© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Clin Chem Lab Med. 2013 Apr;51(4):839-49
pubmed: 23314559
J Trace Elem Med Biol. 2011 Jan;25(1):19-26
pubmed: 21242073
Sci Total Environ. 2016 Feb 1;543(Pt A):628-635
pubmed: 26613516
Environ Health Perspect. 2005 Jan;113(1):36-42
pubmed: 15626645
BMC Public Health. 2016 Dec 7;16(1):1231
pubmed: 27927239
Sci Total Environ. 2013 Oct 1;463-464:102-10
pubmed: 23792252
Subst Abuse Treat Prev Policy. 2017 Oct 5;12(1):43
pubmed: 28982369
Biosci Rep. 2017 Oct 31;37(5):
pubmed: 28916729
Medicine (Baltimore). 2016 Jan;95(1):e2223
pubmed: 26735529
J Basic Clin Physiol Pharmacol. 2007;18(2):87-100
pubmed: 17715565
J Occup Environ Med. 1997 Jan;39(1):58-62
pubmed: 9029432
Am J Ind Med. 1993 May;23(5):763-77
pubmed: 8506854
Int J Hyg Environ Health. 2013 Jun;216(3):243-9
pubmed: 22748699
Basic Clin Pharmacol Toxicol. 2018 Jan;122(1):56-64
pubmed: 28802093
Int J Hyg Environ Health. 2004 Jan;207(1):69-73
pubmed: 14762976
J Occup Environ Med. 2003 Jul;45(7):724-33
pubmed: 12855913
Environ Int. 2011 Apr;37(3):565-71
pubmed: 21237512
Int J Occup Environ Med. 2010 Oct;1(4):182-90
pubmed: 23022807
Am J Med. 2016 Nov;129(11):1213-1218
pubmed: 27341956
Int Arch Occup Environ Health. 2011 Jan;84(1):53-63
pubmed: 20198383
Daru. 2012 Aug 28;20(1):8
pubmed: 23351197
Food Chem Toxicol. 2013 Jul;57:161-9
pubmed: 23537601
Daru. 2012;20(1):2
pubmed: 23226111
Br J Ind Med. 1991 Oct;48(10):696-701
pubmed: 1931729
Int J Hyg Environ Health. 2012 Feb;215(2):109-19
pubmed: 22014893
Environ Health Perspect. 2016 Jan;124(1):97-103
pubmed: 26091556
Curr Environ Health Rep. 2016 Dec;3(4):416-433
pubmed: 27783356
Int J Hyg Environ Health. 2011 Dec;215(1):26-35
pubmed: 21820957
Int Arch Occup Environ Health. 1999 Jul;72(4):255-60
pubmed: 10491780
Environ Health. 2009 Apr 03;8:15
pubmed: 19344498
Occup Environ Med. 2015 Sep;72(9):625-32
pubmed: 25872777

Auteurs

Sareh Nakhaee (S)

Medical Toxicology and Drug Abuse Research Center (MTDRC), Birjand University of Medical Sciences, Birjand, Iran.
Student Research Committee, Birjand University of Medical Sciences, Birjand, Iran.

Alireza Amirabadizadeh (A)

Medical Toxicology and Drug Abuse Research Center (MTDRC), Birjand University of Medical Sciences, Birjand, Iran.

Samaneh Nakhaee (S)

Medical Toxicology and Drug Abuse Research Center (MTDRC), Birjand University of Medical Sciences, Birjand, Iran.

Mahmood Zardast (M)

Medical Toxicology and Drug Abuse Research Center (MTDRC), Birjand University of Medical Sciences, Birjand, Iran.

Jonathan Schimmel (J)

Denver Health, Rocky Mountain Poison and Drug Center, Denver, Colorado, USA.

Jalil Ahmadian-Moghadam (J)

Department of Emergency Medicine, Gonabad University of Medical Sciences, Gonabad, Iran.

Ayob Akbari (A)

Medical Toxicology and Drug Abuse Research Center (MTDRC), Birjand University of Medical Sciences, Birjand, Iran.

Homeira Mohammadian Darmian (H)

Student Research Committee, Birjand University of Medical Sciences, Birjand, Iran.

Maryam Mohammadi (M)

Student Research Committee, Birjand University of Medical Sciences, Birjand, Iran.

Omid Mehrpour (O)

Medical Toxicology and Drug Abuse Research Center (MTDRC), Birjand University of Medical Sciences, Birjand, Iran.
Denver Health, Rocky Mountain Poison and Drug Center, Denver, Colorado, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH